Immunization News

[First]  [Previous] |    2     3     4     5     6     7     8     9     10     11    | [Next]  [Last] of 84 page(s)

Autism and pollution: the vital link

Times Online (UK)

by Juliet Rix

May 2, 2006

The number of children with autism has risen dramatically in recent years. In a new book, Richard Lathe argues that pollution and environmental causes may be to blame

At the age of 3, James started to regress. His speech got worse until "he was really only echoing and all he did was run around hardly looking at anyone", says Chris, his father. Severe classic autism was diagnosed. The NHS offered no suggestions for treatment so his desperate parents did their own research, dug into their savings and started to do whatever they thought might help.

US awards $1 billion for cell-based flu vaccines

Cidrap

by Robert Roos

May 4, 2006

In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.

The awards to five pharmaceutical companies are intended to help create an alternative to growing flu vaccines in eggs, the time-consuming production method used since the 1950s, and boost US production capacity. The money comes from $3.3 billion Congress appropriated last December for pandemic preparations by the Department of Health and Human Services (HHS). HHS listed the vaccine makers and their contract awards as follows: GlaxoSmithKline, $274.75 million; MedImmune, $169.6 million; Novartis Vaccines & Diagnostics, $220.51 million; DynPort Vaccine, $40.97 million; and Solvay Pharmaceuticals, $298.59 million.

Heavy metals may be implicated in autism

New Scientist News

May 30, 2006

URINE samples from hundreds of French children have yielded evidence for a link between autism and exposure to heavy metals. If validated, the findings might mean some cases of autism could be treated with drugs that purge the body of heavy metals.

Samples from children with autism contained abnormally high levels of a family of proteins called porphyrins, which are precursors in the production of haem, the oxygen-carrying component in haemoglobin. Heavy metals block haem production, causing porphyrins to accumulate in urine. Concentrations of one molecule, coproporphyrin, were 2.6 times as high in urine from children with autism as in controls. Autism is thought to have a number of unknown genetic and environmental causes.

Ministers bow to pressure to probe 'MMR deaths'

The Daily Mail (UK)

by Julie Wheldon

June 18, 2006

The Government has bowed to pressure for experts to investigate the deaths of two children who died following the controversial MMR jab.

The Department of Health has long insisted that the triple measles mumps and rubella jab is totally safe, despite parental fears it may be linked to autism. But now following the deaths of two toddlers, Anna Duncan and George Fisher, officials have said they will consider any information provided by the families.

Human trials of AIDS vaccine begins

The Hindu

by Tamil Nadu

June 28, 2006

CHENNAI: With the first phase of the AIDS vaccine human trial being kicked off in the city, scientists involved in the trial are looking at absorbing more volunteers for the second such vaccine trial in the country.

The process of fulfilling the requirement of selecting two groups of 16 volunteers each is on, P.R. Narayanan, Director, Tuberculosis Research Centre, an Indian Council of Medical Reaserch body conducting the vaccine trial in Chennai, said on Tuesday. TRC collaborates with YRG Care and the International AIDS Vaccine Initiative on the project, conservatively estimated to cost at least one million USD.

Bangladesh vaccinates 24 million children against polio

People's Daily Online

August 7, 2006

Bangladesh on Sunday began to vaccinate 24 million children below five years against polio, as the virus resurfaced in the country after five years with the detection of new cases.

Bangladeshi government used 700,000 volunteers to vaccinate the children across the country, Health Ministry spokesman Golam Kibria told Xinhua Sunday. Bangladesh was unofficially declared polio-free in 2000, but two cases of polio were detected this year, Kibria said.

Long needles may be best for infant immunization

Pakistan News Service (Islamabad)

August 8, 2006

Infants who get vaccinated with a long needle may have fewer reactions than those immunized with shorter needles, finds a new study.

Local reactions such as redness, swelling, and tenderness decreased significantly with the wider-longer needles over the narrower-shorter ones. They found that the wider-longer needle significantly reduced local reactions at four months of age.

Gates Foundation awards UM medical school $28M

Baltimore Business Journal (MD)

by Stephanie Wentworth

August 9, 2006

The Bill and Melinda Gates Foundation has awarded the University of Maryland School of Medicine's Center for Vaccine Development a $27.9 million grant to study diarrheal diseases.

The money will be used to gather information to develop vaccines and distribute them in the world's poorest countries, the medical center said Wednesday. Diarrheal disease is the second deadliest disease for children worldwide, according to the Institute for OneWorld Health, a nonprofit pharmaceutical company. Nearly 2 million deaths are attributed to diarrheal disease annually, the organization said.

Possible Treatment For Type 1 Diabetes With New Vaccine

Science Daily

September 16, 2006

For the more than one million Americans with type 1 diabetes and the 35,000 children newly afflicted with the disease each year, a new vaccine tested in a human clinical trial holds a great deal of promise.

The research that established the foundation for this vaccine was conducted in UCLA research laboratories. The drug is still being tested and is not likely to be available for at least a few years.

Mercury Madness - FDA Still in Denial

News With Views

by Elissa Meininger

November 7, 2006

Some months ago, I learned that the Food and Drug Administration (FDA) was going to stage another hearing about the safety of dental amalgam (aka mercury) fillings scheduled for September 6 and 7, 2006.

Immediately, like thousands of other victims of mercury poisoning who had monitored the last major FDA hearing in 1991, I wondered if this time the hearing would be objective, or if we would experience the same attempt to cover up what we all knew was a major health crisis fifteen years ago.

[First]  [Previous] |    2     3     4     5     6     7     8     9     10     11    | [Next]  [Last] of 84 page(s)